Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Small Science|April 11, 2025
Design of Versatile Top-Down Transfer by Thermal Release Tape/Poly(methyl methacrylate) (TRT/PMMA) Bi-Supporting Layers Toward All-Transfer Transition Metal Dichalcogenide Material Based Transistor ArraysYing-Chun Shen, Bang-Kai Wu, Tsung-Shun Tsai, et al.Journal for Immunotherapy of Cancer|January 21, 2022
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter studyPaolo Andrea Zucali, Chia-Chi Lin, Bradley C Carthon, et al.Liver Cancer|October 22, 2024
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for OligoprogressionTsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, et al.The Journal of Experimental Medicine|July 16, 2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophagesXiaoyun Li, Sofie Hedlund Møller, Jaeoh Park, et al.Clinical and Molecular Hepatology|August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular CarcinomaI-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.Liver Cancer|July 9, 2026
Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort StudyTeng-Yu Lee, Pei-Chang Lee, Ying-Chun Shen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2024
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus BevacizumabYing-Chun Shen, Tsung-Hao Liu, Alan Nicholas, et al.Pageof 6